News | Artificial Intelligence | December 14, 2022

MedCognetics’ AI enabled breast cancer screening software, QmTRIAGE, has received FDA 510(k) clearance.

MedCognetics’ AI enabled breast cancer screening software, QmTRIAGE, has received FDA 510(k) clearance.

MedCognetics’ AI enabled breast cancer screening software, QmTRIAGE, has received FDA 510(k) clearance. Photo credit: MedCognetics, Inc. 


December 14, 2022 — Dallas, TX-based MedCognetics, Inc. announced it has received U.S Food and Drug Administration (FDA) 510(k) clearance for its AI enabled software for breast cancer screening, QmTRIAGE. The company provides an advanced AI software platform with the goal of reducing time and cost of imaging, and improving outcomes across diverse patient populations, according to a company statement. The platform integrates into radiology workflow and is also training its AI algorithm on a diverse global patient database to mitigate data biasing. MedCognetics has teamed up with the University of Texas at Dallas and University of Texas Southwestern Medical Center (UTSW) in Dallas, Texas to help achieve its goals. 

“The American Cancer Society has stated that in 2022 approximately 287,850 new cases of invasive breast cancer will be diagnosed in women,” said Debasish Nag, chief executive officer, MedCognetics, Inc. “To do so, MedCognetics has partnered with both University of Texas at Dallas and University of Texas Southwestern Medical Center (UTSW) to address these disparities. In addition, our software’s high detection accuracy enables reduced time for review by radiologists, another key component to improved outcomes. The FDA’s clearance is a very important first step for us as we work toward expanding to other realms of cancer,” Nag added.

“The use of AI in medicine has helped bridge many gaps in the detection and treatment of cancers,” said W. Phil Evans, M.D., FACR, Clinical Professor of Radiology at UT Southwestern Medical Center (UTSW), and Chief of its Breast Imaging Division. “We are working to leverage this technology to address data bias regarding breast health and imaging,” noted Evans.

UTSW, which has licensed intellectual property to MedCognetics and holds equity in the company, provided the deidentified clinical data (i.e., breast imaging cases). These assisted in the validation of MedCognetics unbiased AI algorithm. The company also teamed up with UT Dallas, which also holds an equity stake, by licensing intellectual property from its Quality of Life Technology Laboratory. In addition to tackling the trend of training on a dominant ethnic population base, the MedCognetics platform also reduces the amount of time a Radiologist needs to review a case; this is especially vital in underserved communities and areas of the world where medicine and diagnostic imaging are scarce.

According to the statement released by MedCognetics on its FDA clearance, QmTRIAGE provides an unbiased advanced imaging algorithm that leverages AI and Machine Learning (ML) to detect the earliest manifestations of cancer in all ethnicities. The digital health software platform can be deployed on customer premises, via the cloud or through the web – providing customers with one of the most accessible medical AI algorithms on the market.

For information: www.medcognetics.com


Related Content

News | Artificial Intelligence

January 26, 2023 — MedCognetics, Inc., an Artificial Intelligence (AI) software firm, announced that it has been awarded ...

Time January 26, 2023
arrow
News | Artificial Intelligence

Artificial intelligence (AI) is playing a growing role in all our lives and has shown promise in addressing some of the ...

Time January 26, 2023
arrow
News | Digital Pathology

January 25, 2023 — mTuitive, Inc. and PathPresenter Corporation announced a new partnership to deliver an enhanced ...

Time January 25, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

January 25, 2023 — On November 11th, 2022 at the Southern Hills Hospital in Las Vegas, USA, Robotic Spine Surgeon Dr ...

Time January 25, 2023
arrow
Feature | Enterprise Imaging

The Imaging Technology News (ITN) team was saddened to hear of the untimely passing of Frank Pecaitis, US North American ...

Time January 24, 2023
arrow
Feature | Radiology Imaging | By Melinda Taschetta-Millane

Have you read the January/February 2023 issue of Imaging Technology News? If not, take some time out of your busy ...

Time January 24, 2023
arrow
News | Digital Radiography (DR)

January 24, 2023 — Carestream Health was awarded 20 new patents in 2022 for global advances in artificial intelligence ...

Time January 24, 2023
arrow
News | Radiology Imaging

January 23, 2023 — Canon Medical Systems has released a new eBook featuring its new medical imaging roadshow. This new ...

Time January 23, 2023
arrow
News | Artificial Intelligence

January 23, 2023 — PreciseDx, a leading innovator in AI-powered, patient-specific disease analysis, announced its recent ...

Time January 23, 2023
arrow
News | Ultrasound Imaging

January 23, 2023 — Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, introduces ...

Time January 23, 2023
arrow
Subscribe Now